BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6976942)

  • 1. Immunogenetic studies in essential hypertension among black patients. I. Correlative studies of serum autoantibody formation.
    Patel R; Johnson J; Ansari A
    Int Arch Allergy Appl Immunol; 1982; 67(2):145-8. PubMed ID: 6976942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of drug-induced immunologic changes in hypertensive Jamaicans.
    Grell GA; Wilson WA; James O
    South Med J; 1980 Aug; 73(8):1044-5. PubMed ID: 6967624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinuclear antibodies in patients receiving non-practolol beta-blockers.
    Wilson JD; Bullock JY; Sutherland DC; Main C; O'Brien KP
    Br Med J; 1978 Jan; 1(6104):14-6. PubMed ID: 23197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis.
    Chiang CP; Hsieh RP; Chen TH; Chang YF; Liu BY; Wang JT; Sun A; Kuo MY
    J Oral Pathol Med; 2002 Aug; 31(7):402-9. PubMed ID: 12165058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between essential hypertension and immunology].
    Cui H; Wang YM; Kuang YZ
    Zhonghua Nei Ke Za Zhi; 1992 Jan; 31(1):21-3, 60. PubMed ID: 1395907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies and vascular events in essential hypertension: a five-year longitudinal study.
    Kristensen BO; Andersen PL; Wiik A
    J Hypertens; 1984 Feb; 2(1):19-24. PubMed ID: 6530535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic-receptor blockers and antinuclear antibodies in hypertension.
    Booth RJ; Wilson JD; Bullock JY
    Clin Pharmacol Ther; 1982 May; 31(5):555-8. PubMed ID: 6122525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenetics of SLE.
    Walport MJ; Black CM; Batchelor JR
    Clin Rheum Dis; 1982 Apr; 8(1):3-21. PubMed ID: 6811190
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.
    Hochberg MC; Boyd RE; Ahearn JM; Arnett FC; Bias WB; Provost TT; Stevens MB
    Medicine (Baltimore); 1985 Sep; 64(5):285-95. PubMed ID: 2412088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial pulmonary hypertension: immunogenetic findings in four Caucasian kindreds.
    Morse JH; Barst RJ; Fotino M
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):787-92. PubMed ID: 1554203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility antigens in black patients with essential hypertension.
    Patel R; Johnson J
    Circulation; 1981 Nov; 64(5):1042-4. PubMed ID: 7285293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies, histocompatibility antigens and testosterone in males with alcoholic liver cirrhosis.
    Gluud C; Tage-Jensen U; Bahnsen M; Dietrichson O; Svejgaard A
    Clin Exp Immunol; 1981 Apr; 44(1):31-7. PubMed ID: 6973433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between HLA-DRB1, HLA-DQB1 polymorphism and autoantibodies against angiotensin AT(1) receptors in Chinese patients with essential hypertension.
    Zhu F; Sun Y; Wang M; Ma S; Chen X; Cao A; Chen F; Qiu Y; Liao Y
    Clin Cardiol; 2011 May; 34(5):302-8. PubMed ID: 21557256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution of HLA antigens in patients with hypertension].
    Rudnev VI; Pospelov LE; Osipov SG; Suvorov IuI; Malenko AF
    Kardiologiia; 1985 Aug; 25(8):38-40. PubMed ID: 4068458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies specificity in acute anterior uveitis according to the presence of the HLA-B27 allele.
    Trevisani VF; Mattos KT; Esteves RF; Olialves SM; Andrade LE
    Ocul Immunol Inflamm; 2001 Dec; 9(4):231-42. PubMed ID: 11935433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prazosin on the development of antinuclear antibodies in hypertensive patients.
    Wilson JD; Bullock JY; Booth RJ
    Clin Pharmacol Ther; 1979 Aug; 26(2):209-12. PubMed ID: 37015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenetic markers in essential hypertension.
    Kristensen BO
    Clin Exp Hypertens (1978); 1981; 3(4):763-74. PubMed ID: 7297324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
    Sharif R; Fritzler MJ; Mayes MD; Gonzalez EB; McNearney TA; Draeger H; Baron M; ; Furst DE; Khanna DK; del Junco DJ; Molitor JA; Schiopu E; Phillips K; Seibold JR; Silver RM; Simms RW; ; Perry M; Rojo C; Charles J; Zhou X; Agarwal SK; Reveille JD; Assassi S; Arnett FC
    J Rheumatol; 2011 Aug; 38(8):1622-30. PubMed ID: 21572159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential hypertension and histocompatibility antigens. A linkage study.
    Gerbase-DeLima M; DeLima JJ; Persoli LB; Silva HB; Marcondes M; Bellotti G
    Hypertension; 1989 Dec; 14(6):604-9. PubMed ID: 2684855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and titers of antinuclear, antismooth muscle, and other autoantibodies in blood donors.
    Shu S; Nisengard RJ; Hale WL; Beutner EH
    J Lab Clin Med; 1975 Aug; 86(2):259-65. PubMed ID: 1097549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.